BioMimetics.com - Biotech firm specializing in regenerative medicine
Title
BioMimetic Therapeutics, Inc.
Description
Excerpted from the website description:
- BioMimetic Therapeutics, Inc. is an emerging leader in the development and commercialization of drug-device combination products for the repair of orthopedic injuries to bone, cartilage, ligaments and tendons. BioMimetic's suite of products and product candidates combine recombinant protein therapeutics with tissue specific scaffolds, actively stimulating tissue healing and regeneration. BioMimetic's products and product candidates utilize recombinant human Platelet-Derived Growth Factor (rhPDGF-BB), one of the principal wound healing stimulators in the body. rhPDGF-BB is well suited for use in multiple product candidates due to its stimulation of a broad spectrum of cellular events critical for the initiation and progression of orthopedic tissue healing. The Company's first product candidate, GEM 21S® Growth-factor Enhanced Matrix, was recently approved by the FDA for the treatment of bone loss associated with advanced periodontal disease. GEM 21S combines the tissue growth factor rhPDGF-BB with the synthetic bone matrix, Beta-tricalcium phosphate (β-TCP).
Languages
English
Address
- 389-A Nichol Mill Ln
- Franklin TN 37067 US
Additional Information
Related Domains
External Links
Domain Resolution
This domain resolves to the following IP addresses:Categories:
- 21
- 21S
- BMTI
- Beta
- Beta-tricalcium
- Bio
- Biological
- Biologically
- Biomimetic
- Bioscience
- Bone
- Cartilage
- Cell
- Center
- Cool
- Deteriorating
- Deterioration
- Device
- Disease
- Drug
- Enhanced
- FDA
- Factor
- Franklin
- GEM
- Growth
- Growth-factor
- Healing
- Injuries
- Injury
- Joint
- Life
- Ligament
- Loss
- Matrix
- Nashville
- Orthopaedic
- Orthopedic
- Perio
- Periodontal
- Phosphate
- Platelet
- Product
- Protein
- Recombinant
- Regeneration
- RhPDGF-BB
- S
- Science
- Sciences
- Springs
- Synthetic
- Tendon
- Tennessee
- Therapeutic
- Therapeutics
- Tissue
- Treatment
- Tricalcium
- Β-TCP